Immediate Impact

50 standout
Sub-graph 1 of 24

Citing Papers

Persistent physical symptoms: definition, genesis, and management
2024 Standout
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
2 intermediate papers

Works of Emanuele Tarolla being referenced

Suicide risk in skin disorders
2012
Combined Pharmacological and Short-Term Psychodynamic Psychotherapy for Probable Medication Overuse Headache: A Pilot Study
2008

Author Peers

Author Last Decade Papers Cites
Emanuele Tarolla 161 105 23 83 15 323
Sibelnur Avcıl 75 100 27 87 21 291
Silvia Molteni 57 181 19 56 14 298
Cal VanderPlate 61 141 9 20 13 363
Genery D. Booster 132 139 56 41 13 353
S.-G. Consoli 171 37 25 50 17 349
Cristina Rivas 114 68 45 83 10 311
Magda Liakopoulou 156 32 5 10 16 332
Melissa Silverman 190 41 11 34 20 306
A. A. Mason 55 43 33 147 19 313
Andrew R. Thompson 198 27 15 73 19 307

All Works

Loading papers...

Rankless by CCL
2026